Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion

Genes and Development

Volumn 13, Issue 1, 1999, Pages 35-48

  Yu, Qin ^a   Stamenkovic, Ivan ^a  

^a NONE

Author keywords

CD44; Cell surface; Invasion; MMP 9; Tumor

Indexed keywords

GELATINASE B; HERMES ANTIGEN;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CANCER INVASION; CELL ADHESION; CELL SURFACE; CELLULAR DISTRIBUTION; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALIA;

EID: 0032926177     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.13.1.35     Document Type: Article

References (51)

1. Alexander, C.M., E.J. Hansell, O. Behrendtsen, M.L. Flannery, N.S. Kishnani, S.P. Hawkes, and Z. Werb. 1996. Expression and function of matrix metalloproteinases and their inhibitors at maternal-embryonic boundary during mouse embryo implantation. Development 122: 1723-1736.
2. Aruffo, A., I. Stamenkovic, M. Melnick, C.B. Underhill, and B. Seed. 1990. CD44 is the principal cell surface receptor for hyaluronate. Cell 61: 1303-1313.
3. Bartolazzi, A., R. Peach, A. Aruffo, and I. Stamenkovic. 1994. Interaction between CD44 and hyaluronan is directly implicated in the regulation of tumor development. J. Exp. Med. 180: 53-66.
4. Basbaum, C. and Z. Werb. 1996. Focalized proteolysis: Spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr. Opin. Cell Biol. 8: 731-738.
5. Bennett, K.L., B. Modrell, B. Greenfield, A. Bartolazzi, I. Stamenkovic, R. Peach, D.G. Jackson, F. Spring, and A. Aruffo. 1995a. Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J. Cell Biol. 131: 1623-1633.
6. Bennett, K.L., D.G. Jackson, J.C. Simon, E. Tanczos, R. Peach, B. Modrell, I. Stamenkovic, G. Plowman, and A. Aruffo. 1995b. CD44 isoforms containing exon v3 are responsible for the presentation of heparin-binding growth factors. J. Cell Biol. 128: 687-698.
7. Birkedal-Hansen, H. 1995. Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell Biol. 7: 728-735.
8. v β3. Cell 85: 683-693.
9. Brooks, P.C., S. Silletti, T.L. von Schalscha, M. Friedlander, and D.A. Cheresh. 1998. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 92: 391-400.
10. Clement, M.V. and I. Stamenkovic. 1994. Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions. J. Exp. Med. 180: 557-567.
11. Culty, M., M. Shizari, E.W. Thompson, and C.B. Underhill. 1994. Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44. J. Cell. Physiol. 160: 275-286.
12. Fotouhi, N., A. Lugo, M. Visnick, L. Lusch, R. Walsky, J.W. Coffey, and A.C. Hanglow. 1994. Potent peptide inhibitors of stromelysin based on the prodomain region of matrix metallopremases. J. Biol. Chem. 269: 30227-30231.
13. Garbisa, S., R. Pozzatti, R.J. Muschel, U. Saffiotti, M. Ballin, R.H. Goldfarb, G. Khoury, and L.A. Liotta. 1987. Secretion of type IV collagenolytic protease and metastatic phenotype: Induction by transfection with c-Ha-ras but not c-Has-ras plus Ad2-Ela. Cancer Res. 47: 1523-1528.
14. Gomis-Ruth, F-X., K. Maskos, M. Betz, A. Bergner, R. Huber, K. Suzuki, N. Yoshida, H. Nagase, K. Brew, G.P. Bourenkov, H. Bartunik, and W. Bode. 1997. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 388: 77-81.
15. Gunthert, U., M. Hofmann, W. Rudy, S. Reber, M. Zoller, I. Haussmann, S. Matzku, A. Wenzel, H. Ponta, and P. Herrlich. 1991. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65: 13-24.
16. Herron, G.S., M.J. Banda, E.J. Clark, J. Gavrilovic, and Z. Werb. 1986. Secretion of metalloproteinases by stimulated capillary epithelial cells. J. Biol. Chem. 261: 2814-2818.
17. Jalkanen, S. and M. Jalkanen. 1992. Lymphocyte CD44 binds the COOH-termmal heparin-binding domain of fibronectin. J. Cell Biol. 116: 817-825.
18. Jalkanen, S., H. Joensuu, K.O. Soderstrom, and P. Klemi. 1991. Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma. J. Clin. Invest. 87: 1835-1840.
19. Kaya, G., I. Rodriguez, L. Jorcano, P. Vassalli, and I. Stamenkovic. 1997. Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. Genes & Dev. 11: 996-1007.
20. Kitson, R.P., P.M. Appasamy, U. Nannmark, P. Albertsson, M.K. Gabauer, and R.H. Goldfarb. 1998. Matrix metalloproteinases produced by rat IL-2-activated NK cells. J. Immunol. 160: 4248-4253.
21. Kleiner, D.E. and W.G. Stetler-Stevenson. 1993. Structural biochemistry and activation of matrix metalloproteinase. Curr. Opin. Cell Biol. 5: 891-897.
22. Lesley, J., R. Hyman, and P. Kincade. 1993. CD44 and its interaction with extracellular matrix. Adv. Immunol. 54: 271-335.
23. Liotta, L.A., P.S. Steeg, and W. Stetler-Stevenson. 1991. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64: 327-336.
24. Mignatti, P. and D. Rifkin. 1993. Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73: 161-195.
25. Odake, S., Y. Morita, T. Morikawa, N. Yoshida, H. Hori, and Y. Nagal. 1994. Inhibition of matrix metalloproteinase by peptidyl hydroxamic acids. Biochem. Biophys. Res. Commun. 199: 1442-1446.
26. Ogata, Y., Y. Itoh, and H. Nagase. 1995. Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinase-1 complex by 4-aminophenylmercuric acetate and proteinases. J. Biol. Chem. 270: 18506-18511.
27. Okada, Y., K. Naka, K. Kawamura, T. Matsumoto, I. Nakanishi, M. Fujimoto, H. Sato, and M. Seiki. 1995. Localization of matrix metalloproteinase-9 in osteoclasts: implication for bone resporption. Lab. Invest. 72: 311-322.
28. Pals, S., E. Horst, G. Ossekoppele, C. Figdor, R. Scheper, and C. Meijer. 1989. Expression of lymphocyte homing receptor as a mechanism of dissemination in non-Hodgkin's lymphoma. Blood 37: 885-888.
29. Pan, G., J.Ni, Y.F. Wei, G. Yu, R. Gentz, and V.M. Dixit. 1997. An antagonist decoy receptor and a death-domain-containing receptor for TRAIL. Science 277: 815-818.
30. Peach R.J., D. Hollenbaugh, I. Stamenkovic, and A. Aruffo. 1993. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J. Cell Biol. 122: 257-264.
31. Schnaper, H.W., D.S. Grant, W.G. Stetler-Stevenson, R. Fridman, G. D'Orazi, A.N. Murphy, R.E. Bird, M. Hoythya, T.R. Fuerst, D.L. Frence, J.P. Quigley, and H.K. Kleinman. 1993. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J. Cell. Physiol. 156: 235-246.
32. Screaton, G.R., M.V. Bell, D.G. Jackson, F.B. Cornelis, U. Gerth, and J.I. Bell. 1992. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. 89: 12160-12164.
33. Screaton, G.R., M.V. Bell, J.I. Bell, and D.G. Jackson. 1993. The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor: Comparison of all 10 variable exons between mouse, human, and rat. J. Biol. Chem. 268: 12235-12238.
34. Seiter S., R. Arch, S. Reber, D. Komitowski, M. Hofmann, H. Ponta, H., P. Herrlich, S. Matzku, and M. Zoller. 1993. Prevention of tumor metastasis formation by anti-variant CD44. J. Exp. Med. 177: 443-455.
35. Sherman, L., D. Wainwright, H. Ponta, and P. Herrlich. 1998. A splice variant of CD44 expressed in the apical ectoderm ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth. Genes & Dev. 12: 1058-1071.
36. Sleeman, J.P., W. Rudy, M. Hofamnn, J. Moll, P. Herrlich, H. Ponta. 1996a. Regulated clustering of variant CD44 proteins increases their hyaluronan binding capacity. J. Cell Biol. 135: 1139-1150.
37. Sleeman, J.P., S. Arming, J.F. Moll, A. Hekele, W. Rudy, L.S. Sherman, G. Kreil, H. Ponta, and P. Herrlich. 1996b. Hyaluronan-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells. Cancer Res. 56: 3134-3141.
38. Southern, J.A., D.F. Young, F. Heaney, W. Baumgartner, and R.E. Randall. 1991. Identification of an epitope on the P and V proteins of Simian virus 5 that distinguishes between two isolates with different biological characteristics. J. Gen. Virol. 72: 1551-1557.
39. Stamenkovic, I., A. Aruffo, M. Amiot, and B. Seed. 1991. The hematopoietic and epithelial forms of CD44 are distinct polypeptide with different adhesion potentials for hyaluronan bearing cells. EMBO J. 10: 343-348.
40. Stetler-Stevenson, W.G., S. Aznavoorian, and L.A. Liotta. 1993. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9: 541-573.
41. Sy, M.S., Y-J. Guo, and I. Stamenkovic. 1991. Distinct effects of two CD44 isoforms on tumor growth in vivo. J. Exp. Med. 174: 859-866.
42. Sudbeck, B.D., B.K. Pilcher, H.G. Welgus, and W.C. Parks. 1997. Induction and repression of collagenase-1 by keratinocytes is controlled by distinct components of different extracellular matrix compartments. J. Biol. Chem. 272: 22103-22110.
43. Tanaka, Y., D.H. Adams, S. Hubscher, H. Hirano, U Siebenlist, and S. Shaw. 1993. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β. Nature 361: 79-82.
44. Thomas, L., H.R. Byers, J. Vink, and I. Stamenkovic. 1992. CD44H regulates tumor cell migration on hyaluronan-coated substrate. J. Cell Biol. 118: 971-977.
45. Vu, T.H. and Z. Werb. 1998. Gelatinase B: Structure, regulation, and function. In Matrix metalloproteinases (ed. W.C. Parks and R.P. Mecham), pp. 115-148, Academic Press, San Diego, CA.
46. Vu, T.H., J.M. Shipley, G. Bergers, J.E. Berger, J.A. Helms, D. Hanahan, S.D. Shapiro, R.M. Senior, and Z. Werb. 1998. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93: 411-422.
47. Weber, G.F., S. Ashkar, M.J. Glimcher, and H. Cantor. 1996. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 270: 7437-7444.
48. Wilhelm, S.M., I.E. Collier, B.L. Marmer, A.Z. Eisen, G.A. Grant, and G. Goldberg. 1989. SV40-transformed human lung fibroblasts secrete a 92kDa type IV collagenase which is identical to that secreted by normal macrophages. J. Biol. Chem. 264: 17213-17221.
49. Yu, Q. and B.P. Tooke. 1995. Biotinylated hyaluronan as a probe for detection of binding proteins in cells and tissues. Biotechniques 19: 122-129.
50. Yu, Q., B.P. Toole, and I. Stamenkovic. 1997. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. J. Exp. Med. 186: 1985-1196.
51. Zheng, Z., S. Katoh, Q. He, K. Oritani, K. Miyake, J. Lesley, R. Hyman, A. Hamik, R.M.E. Parkhouse, A.G. Farr, and P.W. Kincade. 1995. Monoclonal antibodies to CD44 and their influence on hyaluronan recognition. J. Cell Biol. 130: 485-495.